Related Experiment Videos
Cyclooxygenase-2 in human perinatal lung.
P Lassus1, H Wolff, S Andersson
1Hospital for Children and Adolescents, University of Helsinki, Finland.
Pediatric Research
|May 17, 2000
Summary
Cyclooxygenase-2 (COX-2) is present in the developing human lung from 16 weeks gestation. Its expression pattern changes throughout gestation and in infants with bronchopulmonary dysplasia, suggesting a role in lung development.
Area of Science:
- Perinatal Medicine
- Pulmonology
- Developmental Biology
Background:
- Cyclooxygenase-2 (COX-2) is a key enzyme in prostanoid synthesis, involved in inflammation and cell growth.
- Understanding COX-2 expression in the developing lung is crucial for identifying its potential roles in perinatal respiratory health.
Purpose of the Study:
- To investigate the presence and pattern of COX-2 expression in human fetal and infant lung tissues.
- To explore the potential developmental role of COX-2 in the perinatal lung.
Main Methods:
- COX-2 immunohistochemistry was performed on autopsy lung tissues from fetuses, preterm infants, term infants, and infants with bronchopulmonary dysplasia (BPD).
- Staining intensity and distribution were analyzed across different gestational ages and clinical groups.
Main Results:
- COX-2 staining was observed in alveolar epithelial cells (type II pneumocytes) and bronchial ciliated epithelial cells.
- Alveolar COX-2 staining was prominent in fetuses, scattered in preterm and term infants, and absent in BPD.
- Bronchial staining was most intense in fetuses and least intense in term infants, with presence in BPD.
Conclusions:
- COX-2 is present in the human perinatal lung from 16 weeks gestation, with a dynamic expression pattern.
- The changing pattern of COX-2 expression suggests it plays a role in human lung development beyond inflammation.